Show simple item record

dc.contributor.authorSalavert, F
dc.contributor.authorHidago, MR
dc.contributor.authorAmadoz, A
dc.contributor.authorCubuk, C
dc.contributor.authorMedina, I
dc.contributor.authorCrespo, D
dc.contributor.authorCarbonell-Caballero, J
dc.contributor.authorDopazo, J
dc.date.accessioned2019-03-28T13:31:27Z
dc.date.available2016-04-22
dc.date.available2019-03-28T13:31:27Z
dc.date.issued2016-05-02
dc.identifier.citationAmadoz, A., et al. (2016). "Actionable pathways: interactive discovery of therapeutic targets using signaling pathway models." Nucleic Acids Research 44(W1): W212-W216.en_US
dc.identifier.issn0305-1048
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/56565
dc.description.abstractThe discovery of actionable targets is crucial for targeted therapies and is also a constituent part of the drug discovery process. The success of an intervention over a target depends critically on its contribution, within the complex network of gene interactions, to the cellular processes responsible for disease progression or therapeutic response. Here we present PathAct, a web server that predicts the effect that interventions over genes (inhibitions or activations that simulate knock-outs, drug treatments or over-expressions) can have over signal transmission within signaling pathways and, ultimately, over the cell functionalities triggered by them. PathAct implements an advanced graphical interface that provides a unique interactive working environment in which the suitability of potentially actionable genes, that could eventually become drug targets for personalized or individualized therapies, can be easily tested. The PathAct tool can be found at: http://pathact.babelomics.org.en_US
dc.description.sponsorshipSpanish Ministry of Economy and Competitiveness [BIO2014-57291-R]; ‘Plataforma de Recursos Biomoleculares y Bioinformáticos’ PT 13/0001/0030 from the ISCIII; co-funded with European Regional Development Funds (ERDF); Generalitat Valenciana (GVA-FEDER) [PROMETEOII/2014/025]; Fundació la Marató TV3 [20133134]; EU FP7-People ITN Marie Curie Project [ref 316861]; EU H2020-INFRADEV-1-2015-1 ELIXIR-EXCELERATE [ref 676559]. Funding for open access charge: Spanish Ministry of Economy and Competitiveness [BIO2014-57291-R];en_US
dc.format.extentW212 - W216
dc.language.isoenen_US
dc.publisherOxford University Pressen_US
dc.relation.ispartofNUCLEIC ACIDS RESEARCH
dc.rightsCreative Commons Attribution License
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subjecttargeted therapiesen_US
dc.subjectDiagnostic strategiesen_US
dc.subjectsignaling pathwaysen_US
dc.titleActionable pathways: interactive discovery of therapeutic targets using signaling pathway modelsen_US
dc.typeArticleen_US
dc.rights.holderThe Author(s) 2016
dc.identifier.doi10.1093/nar/gkw369
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000379786800035&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issueW1en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume44en_US
dcterms.dateAccepted2016-04-22
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Creative Commons Attribution License
Except where otherwise noted, this item's license is described as Creative Commons Attribution License